The spectrum of neuroimaging findings on CT and MRI in adults with COVID-19

G Moonis, CG Filippi, CFE Kirsch… - American Journal of …, 2021 - Am Roentgen Ray Soc
Neurologic involvement is well-recognized in COVID-19. This article reviews the
neuroimaging manifestations of COVID-19 on CT and MRI, presenting cases from the New …

[HTML][HTML] Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection

M Pacheco-Herrero, LO Soto-Rojas… - Frontiers in …, 2021 - frontiersin.org
The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …

[HTML][HTML] Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis

A Vahedian-Azimi, SM Mohammadi… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Results The final selected studies (n= 24 studies; 32,715 patients) showed significant
reductions in ICU admission (OR= 0.78, 95% CI: 0.58–1.06; n= 10; I 2= 58.5%) and death …

[HTML][HTML] Immune responses in mildly versus critically ill COVID-19 patients

H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

COVID‐19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances

AJF Westheim, AV Bitorina, J Theys… - Obesity …, 2021 - Wiley Online Library
Coronaviruses are constantly circulating in humans, causing common colds and mild
respiratory infections. In contrast, infection with the novel severe acute respiratory syndrome …

Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity

HM Al-Kuraishy, AI Al-Gareeb, YQ Almulaiky… - European journal of …, 2021 - Elsevier
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the responsible agent for
the coronavirus disease 2019 (Covid-19), has its entry point through interaction with …

Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection

N Bozorgmehr, S Mashhouri, E Perez Rosero, L Xu… - MBio, 2021 - Am Soc Microbiol
The outbreak of SARS-CoV-2 infection has enormously impacted our lives. Clinical
evidence has implicated the emergence of cytokine release syndrome as the prominent …

Thrombotic risk in children with COVID-19 infection: a systematic review of the literature

M Zaffanello, G Piacentini, L Nosetti, S Ganzarolli… - Thrombosis …, 2021 - Elsevier
Objective Coagulation and inflammatory parameters are mildly altered in children with
SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and …

Immunity and inflammatory biomarkers in COVID‐19: a systematic review

APD Iwamura, MR Tavares da Silva… - Reviews in medical …, 2021 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …

[HTML][HTML] Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review

V Viswanathan, A Puvvula, AD Jamthikar… - World journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic where several
comorbidities have been shown to have a significant effect on mortality. Patients with …